'historic' herbs mentioned in the paper are routinely dispensed by the local pharmacy, e.g. Filipendula ulmaria (meadowsweet), Glycyrrhiza glabra (liquorice). Patients referred to the medical herbalist are prescribed an alcohol-based tincture comprising 1-6 different species. The whole plant is used in such preparations, and not an isolated extract of an individual compound as would be the case in the preparation of a plant-derived drug within the pharmaceutical industry. The materia medica comprises about 150 different herbs, mainly dispensed as tinctures but some as topical preparations. These forms of prescriptions clearly distinguish European herbal medicine from homoeopathy and Chinese herbal medicine whose clinical practices and materia medica are entirely different. There is much media confusion regarding these three 'alternative' therapies.
We have found that certain conditions respond better to herbal medicine than to orthodox drugs e.g. irritable bowel syndrome and other gastrointestinal disorders, the treatment of which has become a special interest of the medical herbalist at this centre. Some of the herbs' unique properties (not mirrored by any allopathic alternatives) allow safe effective relief from symptoms which cannot be controlled by standard preparations.
The information derived from modern biochemical analyses of medicinal plants allows the historic uses to be fully appreciated and understood on a sound scientific basis. Thus today's medical herbalist can achieve excellent results by drawing upon the latest research as well as on a wealth of historical data. (December 1996 JRSM pp681-7) elegantly demonstrate the reduced use of central inpatient services associated with the availability of community hospital beds. However, I was surprised to find no reference to work I published with colleagues in 1994 recording a decrease in cancer deaths in central specialist inpatient beds (district general hospital) where community hospital beds were available to general practitioners.1 Our data, collected in an analogous situation in Exeter and East Devon, revealed that the place of death for patients with access to community hospital beds was as follows: home 29%; community hospital 39%; DGH 17%; nursing or residential home or hospice 14%. For patients without access to community hospital beds the place of death was home 41%, DGH 39%, nursing or residential homes and hospice 20%.
The presence of community hospital beds was associated with a significant reduction of deaths in the DGH (P<0.001) and with a greater number of patients receiving terminal care under their own general practitioner (74% of cases with community hospital beds versus 51% of cases without community hospital beds, P<0.001). By extrapolation to the rest of the UK we estimated that around 8% of all cancer patients might be dying in community hospital beds, a figure approaching that occurring in inpatient hospice beds.2
Hine and colleagues are right to state that community hospitals are one option for providing accessible (and appropriate) care and merit systematic evaluation of costs and benefits. This is one of the stated aims of the Community Hospitals Association (CHA), and I would encourage researchers to communicate details ofwork in progress or completed to me in my role as CHA committee member with an interest in related research.
David Seamark
The Hospice, 1991 Hospital-at-home
We were disappointed to read (October 1996 JRSM, pp548-551) that a hospital-athome service providing intensive home care for the early discharge of adult patients was more expensive than keeping the patients in hospital. For 4 years we have had a children's hospital-at-home service providing care for children discharged home early. This has included children on traction with fractured femur and children on traction following operations for congenital dislocation of the hip. In no case have children's nurses visited the home after traction has been discontinued. The average length of stay in hospital of children having fractured femurs or hip surgery has been reduced from 6 weeks to I week. This service avoids children being unnecessarily kept for long periods in hospital. The children require one visit a day by a nurse, and we have had no complications. We would not want the financial failure of an adult hospital-at-home service to discredit the concept of what is both a humane and a cost-effective way of treating young children at home who are on traction for several weeks.
C H Cheetham K S H Wise
Wycombe Hospital, High Wycombe, Buckinghamshire HP1 1 2TT, England Is the erythrocyte sedimentation rate outdated? Kanfer and Nicol (January 1997 JRSM, pp 16-18 ) advocate abandonment of the erythrocyte sedimentation rate (ESR) in favour of plasma viscosity. This would be premature, until viscosity can be measured as an emergency, 24 hours a day. Let me give an example. Giant cell arteritis, characterized by a high ESR, is one of the greatest emergencies in general medical practice. A quick estimation of ESR is required in any patient around age 60 who complains of intractable headache, particularly occipital and temporal, pain in the face, jaw and mouth exacerbated by chewing, with tenderness over the scalp and over the temporal and cranial arteries. In such a case steroid treatment must be started immediately, and the patient should not leave until the ESR is known. In less obvious cases steroids may reasonably be withheld pending the result of an ESR done on the spot, but not for the time taken by a routine hospital laboratory to measure viscosity. The ESR, simple to estimate, is ideal for the doctor's surgery, for the district hospital's outpatient clinic, and for use at the bedside. A delay of even a few hours in starting steroid therapy may result in irreversible visual failure'. Further, an elderly patient presenting with sudden loss of vision in one or both eyes requires an immediate intravenous injection of 10 mg
